MetaCap

Agios Pharmaceuticals Statistics

NASDAQ: AGIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

27.60-1.16 (-4.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Agios Pharmaceuticals by the numbers

Agios Pharmaceuticals has a market capitalization of $1.65 billion based on 59.81M shares outstanding. With trailing EPS of $-6.31, Agios Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.4% below its 50-day average and 13.4% below its 200-day average.

Average daily trading volume is 1.06M shares, or about $29.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AGIO valuation vs. peer median

AGIO compared with the median of 8 peer companies
MetricAGIOPeer medianDifference
Market cap$1.65B$1.70B-3%
Avg. volume1.06M709.88K+49%

Peer median across 8 companies: BRVE, RARE, ZBIO, KRSA, SDGR, ANIP, TRAX, STOK.

Valuation

Price / sales (latest FY)
30.55
EPS (TTM)
$-6.31

Price and trading

Previous close
28.76
Open
28.01
Day range
27.43 – 29.14
52-week range
24.16 – 44.09
52-week change
+9.35%
Beta
—
Volume
776.16K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.65B
Forward Pe
-8.64
Eps
-6.31
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
44.09
Week52 Low
24.16
Avg Volume
1.06M
Shares Outstanding
59.81M
Ma50
32.64
Ma200
31.89
Earnings Date
Nov 5, 2026
Pct From52w High
-37.40%
Pct From52w Low
14.24%

Related